GLP-1 • GIP • GLUCAGON
RESEARCH PEPTIDES
AUSTRALIA

Retatrutide is a next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously — making it the most advanced metabolic research compound available. Studies have demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with research subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles. This 20mg vial offers researchers a high-purity supply for extended study protocols. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.

Retatrutide 30mg offers an extended research supply of the groundbreaking triple agonist (GLP-1, GIP, glucagon) compound that is reshaping metabolic science. Retatrutide has shown greater efficacy in weight loss research than any previous generation of incretin-based peptides, with studies reporting double-digit percentage reductions in body mass. This larger 30mg vial is ideal for longer-duration protocols or comparative dose-response studies. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.

Tirzepatide is a dual GIP/GLP-1 receptor agonist that has set new benchmarks in metabolic and weight loss research. As the compound behind some of the most significant findings in obesity science, tirzepatide demonstrates powerful effects on appetite regulation, glucose metabolism, and adipose tissue reduction. This 30mg vial provides researchers with an ample supply for comprehensive study protocols. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.

Semax is a synthetic heptapeptide derived from ACTH and classified as a nootropic research compound. Originally developed in Russia, Semax has been extensively studied for its neuroprotective, cognitive-enhancing, and neurological recovery properties. Research indicates it may upregulate BDNF (brain-derived neurotrophic factor), supporting neuroplasticity and cognitive function. Studies have also explored its role in stroke recovery, anxiety modulation, and attention enhancement. This 10mg vial is HPLC-verified for research use. Lyophilised powder, requires reconstitution.

Selank is a synthetic anxiolytic peptide analogue of tuftsin, developed for research into anxiety, mood regulation, and cognitive performance. Studies indicate Selank modulates GABAergic and serotonergic systems, producing anxiolytic effects without the sedation or dependency associated with benzodiazepines. Research has also explored its potential in immune modulation and memory enhancement. A popular subject of nootropic research, Selank is of particular interest to scientists studying stress response and mental performance. Third-party tested, 10mg lyophilised powder.

MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial genome, representing a frontier area of longevity and metabolic research. Studies have shown MOTS-c plays a critical role in regulating insulin sensitivity, exercise capacity, and metabolic homeostasis. Research in animal models suggests MOTS-c may mimic the metabolic benefits of exercise, making it of significant interest for obesity, diabetes, and age-related metabolic decline research. This 10mg vial is HPLC-verified. Lyophilised powder, requires reconstitution with bacteriostatic water.

This 40mg vial of MOTS-c provides researchers with an extended supply of this remarkable mitochondrial-derived peptide. MOTS-c has attracted significant scientific attention for its role in metabolic regulation, insulin sensitivity, and the biology of ageing. Research suggests it activates AMPK pathways — the same pathway targeted by exercise and caloric restriction — positioning it as a key subject in longevity and metabolic disease research. Ideal for longer-duration or higher-dose comparative studies. Third-party HPLC tested. Lyophilised powder.

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme central to cellular energy metabolism and a key subject in longevity research. NAD+ levels decline significantly with age, and research has linked this decline to reduced mitochondrial function, impaired DNA repair, and accelerated cellular ageing. Studies exploring NAD+ restoration have shown promising results in areas including metabolic health, neurological function, and cellular resilience. This 100mg research-grade NAD+ vial is suitable for in vitro studies and preclinical research protocols.

SS-31 (also known as Elamipretide) is a mitochondria-targeting peptide that has emerged as one of the most compelling compounds in cellular health and longevity research. By selectively accumulating in the inner mitochondrial membrane and stabilising cardiolipin, SS-31 helps restore mitochondrial function and reduce oxidative stress. Research has demonstrated potential applications in cardiac protection, age-related mitochondrial decline, kidney injury, and neurodegenerative conditions. This 10mg vial is HPLC-verified. Lyophilised powder, requires reconstitution.

This 50mg vial of SS-31 (Elamipretide) offers an extended research supply of one of the most exciting mitochondria-targeted peptides in modern science. SS-31 has shown remarkable results in preclinical research across cardiovascular protection, renal function, neurodegeneration, and the fundamental biology of ageing. Its unique ability to penetrate and stabilise the inner mitochondrial membrane makes it a standout compound for researchers studying oxidative stress and mitochondrial dysfunction. Third-party HPLC tested. Lyophilised powder.

BPC-157 (Body Protection Compound-157) is one of the most widely studied peptides in regenerative medicine research. Derived from a protein found in gastric juice, BPC-157 has demonstrated remarkable healing properties across a broad range of tissues in preclinical studies — including tendons, ligaments, muscles, bone, and the gastrointestinal tract. Research also suggests significant benefits for gut health, inflammatory modulation, and angiogenesis. This 20mg vial provides an extended research supply of HPLC-verified, high-purity BPC-157. Lyophilised powder, requires reconstitution with bacteriostatic water.

The BPC-157 and TB-500 blend combines two of the most researched regenerative peptides into a single, convenient vial. BPC-157 is renowned for its tissue healing, gut repair, and anti-inflammatory properties, while TB-500 (Thymosin Beta-4) promotes cell migration, angiogenesis, and systemic recovery. Together, research suggests these peptides create a powerful synergistic effect — making this blend one of the most popular combinations studied for musculoskeletal recovery, injury repair, and tissue regeneration. 5mg BPC-157 + 5mg TB-500 per vial. HPLC-verified. Lyophilised powder.

The CJC-1295 and Ipamorelin combination is one of the most studied growth hormone secretagogue stacks in peptide research. CJC-1295 (without DAC) is a GHRH analogue that stimulates growth hormone release, while Ipamorelin is a selective GH secretagogue that amplifies that release with minimal effect on cortisol or prolactin. Research indicates this combination produces robust, pulsatile GH release, making it of significant interest for studies on muscle protein synthesis, fat metabolism, recovery, and age-related GH decline. 5mg CJC-1295 + 5mg Ipamorelin per vial. HPLC-verified. Lyophilised powder.

PT-141 (Bremelanotide) is a melanocortin receptor agonist and one of the most researched peptides in the field of sexual health science. Unlike traditional approaches that target the vascular system, PT-141 acts centrally via the nervous system — specifically activating MC3R and MC4R receptors — to study the neurological pathways of sexual arousal and function. Research has explored its applications in both male and female sexual dysfunction, with studies demonstrating effects on libido and arousal independent of hormonal levels. This 10mg vial is HPLC-verified. Lyophilised powder, requires reconstitution.

KPV (Lys-Pro-Val) is a tripeptide fragment derived from alpha-melanocyte stimulating hormone (α-MSH), notable for its potent anti-inflammatory and gut-protective properties. Research has demonstrated KPV's ability to suppress inflammatory pathways through inhibition of NF-κB signalling, with studies exploring applications in inflammatory bowel disease, colitis, and mucosal healing models. Additional research has investigated KPV's role in wound healing, skin barrier function, and antimicrobial defence. This 10mg vial provides an ample research supply of HPLC-verified KPV. Lyophilised powder, requires reconstitution with bacteriostatic water.

KLOW is a precision research blend combining four of the most studied regenerative and anti-inflammatory peptides into a single high-concentration vial. GHK-Cu (50mg) anchors the formulation — a copper tripeptide with extensive evidence for wound healing, collagen synthesis, anti-inflammatory activity, and skin barrier repair. KPV (10mg) contributes potent NF-κB inhibition and gut-protective properties, while BPC-157 (10mg) provides the broad tissue-healing and angiogenic effects that have made it one of the most referenced peptides in regenerative research. TB-500 (Thymosin Beta-4, 10mg) rounds out the blend with systemic recovery support, cell migration promotion, and musculoskeletal repair signalling. Together, this combination targets multiple overlapping repair pathways simultaneously — making KLOW of particular interest to researchers studying complex tissue injury, chronic inflammation, and accelerated recovery models. 80mg total per vial. HPLC-verified. Lyophilised powder, requires reconstitution with bacteriostatic water.

Human Growth Hormone (somatotropin, HGH) is a 191-amino acid peptide hormone secreted by the anterior pituitary gland and a central subject in research on growth, body composition, metabolism, and longevity. Recombinant HGH research has explored applications in muscle protein synthesis, adipose tissue metabolism, bone mineral density, and age-related decline in endogenous GH secretion. This research kit contains 10 vials of 10IU each, totalling 100IU of research-grade lyophilised HGH. HPLC-verified purity. Each vial requires reconstitution with bacteriostatic water prior to use.

Bacteriostatic water (0.9% benzyl alcohol in sterile water for injection) is an essential reconstitution solvent for lyophilised research peptides, hormones, and compounds. The benzyl alcohol preservative inhibits microbial growth, allowing safe repeated access to the same vial over extended research protocols. This 10mL vial provides a generous volume suitable for reconstituting multiple compounds or single larger-volume preparations. An indispensable consumable for any peptide research laboratory. USP-grade sterile solution.

Bacteriostatic water (0.9% benzyl alcohol in sterile water for injection) is the standard reconstitution solvent for lyophilised research peptides and compounds. The benzyl alcohol preservative maintains sterility across multiple draws, making it ideal for ongoing research protocols. This compact 3mL vial is suited to single-compound reconstitution or lower-volume research applications. An essential consumable for researchers working with lyophilised peptides. USP-grade sterile solution.

Epitalon (epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a pineal gland extract studied since the 1980s for its effects on telomerase activity, circadian regulation, and biological ageing markers. Research has examined epitalon role in melatonin secretion, telomere length, and antioxidant pathways, with longevity studies in model organisms reporting extended lifespan endpoints. This 10mg vial provides a high-purity supply for ageing and circadian-rhythm research protocols. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.

Semaglutide is a GLP-1 receptor agonist peptide with a molecular weight of approximately 4,113.58 Da. Each vial contains 10mg of lyophilised semaglutide (>98% purity by HPLC), manufactured under research-grade conditions and third-party tested. Supplied as a sterile lyophilised powder. Requires reconstitution with bacteriostatic water prior to use. Store lyophilised peptide at -20°C; reconstituted solution stable for up to 28 days at 4°C. Intended for research purposes only. Not for human use.

Human Growth Hormone (somatotropin, HGH) is a 191-amino acid peptide hormone secreted by the anterior pituitary gland and a central subject in research on growth, body composition, metabolism, and longevity. Recombinant HGH research has explored applications in muscle protein synthesis, adipose tissue metabolism, bone mineral density, and age-related decline in endogenous GH secretion. This research kit contains 10 vials of 24IU each, totalling 240IU of lyophilised HGH — sized for extended study protocols. HPLC-verified purity. Each vial requires reconstitution with bacteriostatic water prior to use.

Human Growth Hormone (somatotropin, HGH) is a 191-amino acid peptide hormone secreted by the anterior pituitary gland and a central subject in research on growth, body composition, metabolism, and longevity. Recombinant HGH research has explored applications in muscle protein synthesis, adipose tissue metabolism, bone mineral density, and age-related decline in endogenous GH secretion. This bulk research kit contains 10 vials of 40IU each, totalling 400IU of lyophilised HGH — the largest supply tier, suited to long-duration or comparative protocols. HPLC-verified purity. Each vial requires reconstitution with bacteriostatic water prior to use.

Retatrutide 10mg provides a compact research supply of the next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously — the most advanced incretin-based compound currently under metabolic study. Research has demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles. This 10mg vial suits shorter protocols or dose-finding studies. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.

Tirzepatide is a dual GIP/GLP-1 receptor agonist that has set new benchmarks in metabolic and weight loss research. As the compound behind some of the most significant findings in obesity science, tirzepatide demonstrates powerful effects on appetite regulation, glucose metabolism, and adipose tissue reduction. This 15mg vial provides researchers with an ample supply for comprehensive study protocols. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.

GHK-Cu (Glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide-copper(II) complex first isolated from human plasma in 1973, making it one of the longest-studied copper-binding peptides in research. Plasma GHK-Cu levels decline with age — from approximately 200 ng/mL at 20 to under 80 ng/mL by 60 — paralleling the drop in dermal repair capacity. Research has shown GHK-Cu influences expression of over 4,000 human genes, stimulates collagen I, III and elastin synthesis, activates matrix metalloproteinases for extracellular matrix remodelling, supports angiogenesis through VEGF and FGF upregulation, and suppresses pro-inflammatory TNF-α signalling. Each 50mg vial is supplied for laboratory investigation of dermal biology, copper-dependent peptide signalling, and follicle-research applications. CAS 49557-75-7. For research use only — not for human consumption.

BPC-157 (Body Protection Compound-157) is one of the most widely studied peptides in regenerative medicine research. Derived from a protective protein found in gastric juice, BPC-157 has demonstrated remarkable healing properties across a broad range of tissues in preclinical studies — including tendons, ligaments, muscles, bone, and the gastrointestinal tract. Research also suggests significant benefits for gut health, inflammatory modulation, and angiogenesis. This 10mg vial offers a balanced research supply of HPLC-verified, high-purity BPC-157. Lyophilised powder, requires reconstitution with bacteriostatic water.

BPC-157 (Body Protection Compound-157) is one of the most widely studied peptides in regenerative medicine research. Derived from a protective protein found in gastric juice, BPC-157 has demonstrated remarkable healing properties across a broad range of tissues in preclinical studies — including tendons, ligaments, muscles, bone, and the gastrointestinal tract. Research also suggests significant benefits for gut health, inflammatory modulation, and angiogenesis. This 5mg vial provides a small research supply of HPLC-verified, high-purity BPC-157 — ideal for short pilot studies. Lyophilised powder, requires reconstitution with bacteriostatic water.